SLS Stock Logs 2-Day Losing Streak: Mixed Institutional Bets Emerge Ahead Of Key AML Trial Update
Gamma Investing cut its SLS stake by 259 shares, or 32%, holding 556 shares worth about $8,210 as of June 30.
Read the full articleYou might also wanna read
Rocket Lab (NASDAQ: RKLB) CEO Share Sale Deepens Two-Day Selloff Amid $8 Billion Iridium Deal
Rocket Lab Corp. (NASDAQ: RKLB) extended its losing streak for a second consecutive session on Tuesday, falling 10.40 percent to close at $8
Sri Lankan shares extend losing streak to eight sessions on broad-based losses
Sri Lankan shares closed lower for the eighth straight session on Thursday, its longest downward streak since September 2024, dragged by los
Weekly Portfolio Update: €971K Stock Value, Dividend Income & New Purchases
# Stock portfolio value - 971 581 EUR # Purchases - 40 Comcast - 8 Accenture # Received Dividends - 99 USD Jackson Financial - 59 USD P...
finveztor.com·13d agoNurix Therapeutics, Inc. (NRIX) reports Q2 loss, lags revenue estimates
Nurix Therapeutics, Inc. (NRIX) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.73. Th
SpaceX falls for third day, erasing $600 billion in market value
The Elon Musk-led company’s market capitalization now sits just above $2 trillion after shares fell 16% to close at $154.60 on Monday.
This Undervalued $40 Billion Company Is Ready To Soar
$40 billion. That is the market capitalization of Celestica (NYSE:CLS), a company that raised its revenue guidance from $17.0 billion to $19
Comments
Sign in to join the conversation.
No comments yet. Be the first.